section g – special projects scottish renal registry report 2008 published by the information...

Section G – Special Projects

Scottish Renal Registry Report 2008

Published by the Information Services Division (ISD Scotland), Common Services Agency for NHSScotland, 1 South Gyle Crescent, Edinburgh EH12 9EB on behalf of the Scottish Renal Registry © Common Services Agency 2009

Suggested citation : Scottish Renal Association (2009). Scottish Renal Registry Report, 2008. Edinburgh : Information Services Division.ISBN: 978-1-84134-016-6These charts may be reproduced without permission provided the source is acknowledged.

The full report is available on the Scottish Renal Registry website.ISBN: 978-1-84134-016-6

The Scottish Renal Registry4th FloorWalton BuildingGlasgow Royal InfirmaryGLASGOWG4 0SFScotland, UKPhone +00 44 141 211 5171Fax +00 44 141 211 4843Email [email protected] http://www.srr.scot.nhs.uk



Section G1 Survey of staffing levels and facilities in renal units in August 2007



G1.1 Proportion of the adult population served by each renal unit in Scotland on 30 August 2007



G1.2 Number of consultant and non-consultant medical staff (WTE) per 100000 general population by renal unit in Scotland on 30 August 2007



G1.3 Number of in-patient beds available per 100000 population by renal unit in Scotland on 30 August 2007



G1.4 Number of renal ward nursing staff per inpatient bed by renal unit in Scotland on 30 August 2007



G1.5 Percentage inpatient beds plumbed for haemodialysis by renal unit in Scotland on 30 August 2007



G1.6 Number of HD sessions available per 100000 population per week by renal unit in Scotland on 30 August 2007



G1.7 Number of HD sessions per HD station per week by parent unit and satellite unit in Scotland on 30 August 2007



G1.8 Maximum duration and number of HD session offered by renal units in Scotland on 30 August 2007



G1.9 Proportion of HD sessions provided in satellite units by parent renal unit in Scotland on 30 August 2007



G1.10 Percentage HD station segregated for infection control by renal unit in Scotland on 30 August 2007



G1.11 Number of HD nurses per HD session by renal unit in Scotland on 30 August 2007



G1.12 Number of PD nurses (WTE) per prevalent PD patient by renal unit in Scotland on 30 August 2007



G1.13 Number of other staff per 100000 population by renal unit in Scotland on 30 August 2007



G2 Incidence of native renal biopsy in Scotland



G2.1 Number of native renal biopsies PMP/year, all renal units combined



G2.2 Number of biopsies performed per million population per year in each renal unit



G2.3 Number of biopsies performed per million population per year in each renal unit between 2002 and 2006



G2.4 Mean age at time of biopsy by renal unit



G2.5 Percentage of males biopsied in each renal unit by year



G2.6 Reported rates of native renal biopsies from national and regional



G3B Achieved blood pressure of haemodialysis patients: Spring 2007



G3B.1 Distribution of mean pre HD systolic BP in HD patients by renal unit: spring 2007



G3B.2 Distribution of mean pre HD systolic BP in HD patients by renal units: spring 2007



G3B.3 Distribution of mean pre HD diastolic BP in HD patients by renal unit: Spring 2007



G3B.4 Distribution of mean pre HD diastolic BP in HD patients by renal unit: spring 2007



G3B.5 Pre haemodialysis systolic and diastolic BP by PRD group: spring 2007



G4 A Collaborative Study between the Scottish Renal Registry and the Scottish Cancer Registry



G4.1 Number of patients developing malignancy



G4.2 Proportions of patients developing malignancy according to diagnosis group



G5 A novel method for removing lead-time bias from registry data.



G5.1 Cox plot of patient survival by renal unit adjusted for age, sex and PRD 1995-2004



G5.2 Calculated rates of decline in EGFR (mL/min/month) for each of the 5 primary renal diagnosis groups. Data are based on 989 patients starting dialysis at Glasgow Royal Infirmary



G5.3 Box whisker plot of EGFR at start of RRT in Scotland for the 10-year period from 01 January 1995-31 December 2004



G5.4 Hazard ratios of death before and after allowing for lead-time bias. Survival was adjusted for primary renal diagnosis, patient sex and age



G5.5 Cox regression plot of patient survival by adult renal unit adjusted for age, sex and PRD: but not for lead time bias 1995-2004



G5.6 Cox regression plot of patient survival by adult renal unit adjusted for age, sex and PRD: after lead time bias 1995-2004



G6 Vascular access for haemodialysis 2007



G6.1 Types of vascular access for haemodialysis patients in spring 2007



G6.2 Determinants of AV access



G6.3 Percentage of patients with AV access in spring 2007, by time period of starting RRT



G6.4 Percentage of patients with AV access in Spring 2007 by renal unit



G6.5 AV access in spring 2007 by renal unit



G7 Haemodialysis water sampling: current procedures in Scottish renal units



G7.1 Frequency of sampling of haemodialysis water for chemical contaminants



G7.2 Frequency of sampling of haemodialysis water for endotoxins



G7.3 Frequency of sampling of haemodialysis water for bacteria



G7.4 Frequency of sampling of haemodialysis water for chlorines



G7.5 Frequency of sampling of haemodialysis water



G7.6 Place of analysis of haemodialysis water for contaminants



G7.7 Location and method of analysis of haemodialysis water samples



G7.8 Renal unit protocols for response to chemical contaminants



G7.9 Response from renal units to an abnormal haemodialysis water analysis result



G7.9 Response from renal units to an abnormal haemodialysis water analysis result (continued)



G8 Aluminium and other trace metals in haemodialysis water in Scottish renal units 1999-2008



G8.1 Standards for mandatory testing of trace metals in water for dialysis



G8.2 Summary of discretionary testing of trace metals in water for dialysis



G8.3 High trace metal concentrations in treated dialysis water



G8.4a Total number of treated water aluminium samples per year



G8.4b Number of samples with aluminium concentration > 10 microg / L by year



G8.5 Number of treated water samples tested for aluminium by renal unit



G8.6 Number of samples and ROs by renal unit



G8.7 Proportion of treated water samples with aluminium concentration > 10microg/L by renal unit



G8.8 Aluminium concentrations > 10 microg /L in treated dialysis water from QMH Dunfermline by year



G8.9 Aluminium concentrations > 10 microg /L in treated L in treated dialysis water from Monklands Hospital Airdrie by year



G8.10 Repeat testing of initially high treated water aluminium concentration



G8.11 Delay before repeat testing of samples of treated water with aluminium concentration > 10 microg /L



G9 Encapsulating Peritoneal Sclerosis in Scotland



G9.1 Rate of EPS according to duration of PD exposure



G9.2 Cumulative risk of developing EPS from day 1 on PD therapy (censored for death but not change in modality of renal replacement therapy)



G9.3 Number of EPS cases by renal unit



G9.4 EPS cases by year of diagnosis



G9.5a Duration of PD in patients who did not develop EPS



G9.5b Duration of PD in patients who developed EPS



G9.6 Timing of EPS diagnosis in relation to PD therapy



G9.7 Most common presenting clinical features in the EPS cases



G9.8 Drug therapy prescribed to treat EPS or as part of transplant immunosuppression

section g – special projects scottish renal registry report 2008 published by the information...

Documents